Theriva Biologics holds special stockholder meeting
TOVX•Shareholders approved increasing Theriva Biologics’ authorized common stock to 500 million shares and ratified approval to issue up to 16,184,560 shares upon warrant exercise. The board may decide not to implement the authorized-share amendment.




